Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (11)

2022

  1. Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy

    Biochemical Pharmacology, Vol. 192

2020

  1. Dasatinib protects humanized mice from acute HIV-1 infection

    Biochemical Pharmacology, Vol. 174

2019

  1. The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection

    PLoS Pathogens, Vol. 15, Núm. 8

  2. Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV

    Current HIV/AIDS Reports, Vol. 16, Núm. 5, pp. 414-422

2018

  1. Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors

    Biochemical Pharmacology, Vol. 156, pp. 248-264

  2. Factors leading to the loss of natural elite control of HIV-1 infection

    Journal of Virology, Vol. 92, Núm. 5

2017

  1. Potential role of tyrosine kinase inhibitors during primary HIV-1 infection

    Expert Review of Anti-Infective Therapy

2016

  1. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

    Biochemical Pharmacology, Vol. 106, pp. 30-45

2015

  1. An unconventional calmodulin-anchoring site within the AB module of Kv7.2 channels

    Journal of Cell Science, Vol. 128, Núm. 16, pp. 3155-3163

2005

  1. SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives:  Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors

    Journal of Medicinal Chemistry, Vol. 48, Núm. 23, pp. 7103-7112